ADC Therapeutics gewährt neuen Mitarbeitern Zuteilungen im Rahmen des Anreizplans
July 02, 2024 12:27 ET
|
ADC Therapeutics SA
LAUSANNE, Schweiz, July 02, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) hat heute bekanntgegeben, dass das Unternehmen sechs neuen Mitarbeitern am 1. Juli 2024 Zuteilungen für Optionen...
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
July 01, 2024 16:05 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, July 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company has made grants of options to purchase an aggregate of 172,400 of the...
ADC Therapeutics tritt demnächst den Indizes Russell 2000® und Russell 3000® bei
June 27, 2024 12:23 ET
|
ADC Therapeutics SA
LAUSANNE, Schweiz, June 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) hat heute bekanntgegeben, dass das Unternehmen nach Abschluss der jährlichen Neukonstituierung der Russell...
ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
June 27, 2024 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company is set to join the Russell 2000® Index and the broad-market Russell 3000®...
ADC Therapeutics gewährt neuen Mitarbeitern Zuteilungen im Rahmen des Anreizplans
June 03, 2024 18:39 ET
|
ADC Therapeutics SA
LAUSANNE, Schweiz, June 04, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) hat heute die Zuteilung von Optionen zum Kauf von insgesamt 109.800 Stammaktien des Unternehmens an drei neue...
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
June 03, 2024 16:05 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 03, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company has made grants of options to purchase an aggregate of 109,800 of the...
ADC Therapeutics nimmt an der Jefferies Global Healthcare Conference teil
May 30, 2024 19:40 ET
|
ADC Therapeutics SA
LAUSANNE, Schweiz, May 31, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass Ameet Mallik, Chief Executive Officer, am Donnerstag, 6. Juni 2024 um 11:30 Uhr ET an der...
ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will present a company overview at the Jefferies...
ADC Therapeutics wird an der H.C. Wainwright 2nd Annual BioConnect Investor Conference an der NASDAQ teilnehmen
May 16, 2024 04:50 ET
|
ADC Therapeutics SA
LAUSANNE, Schweiz, May 16, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass Ameet Mallik, Chief Executive Officer, an einem Kamingespräch (fireside chat) im Rahmen...
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 15, 2024 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the H.C....